Strategic investors play a major role in defining the winners in telehealth. Their insights and lessons learned - from deals that worked and those that didn't - provide critical insights on the future of the industry.
Grant Chamberlain joined Ziegler in 2015 as a managing director in the Corporate Finance Healthcare Practice. With over 20 years of investment banking experience, Grant has advised some of the leading healthcare systems, including Sharp Healthcare, Cedars-Sinai and Baylor Health, along with several of the most innovative mHealth companies, including AirStrip, MDLive and Voalte.
Prior to Ziegler, Grant led the mHealth sector coverage at Raymond James – which included telehealth, remote monitoring and wireless healthcare solutions – after spending 15 years advising HCIT and tech-enabled outsource services companies on a broad variety of M&A, joint venture/partnerships and private financings.
Prior to Raymond James, Grant was a principal at Shattuck Hammond Partners before it was acquired by Morgan Keegan. He was also a part of the corporate finance group of General Electric Capital Corporation and the financial services division of GE Medical Systems.
In addition, Grant is an elected member of the Board of Directors of the American Telemedicine Association (ATA), the leading international resource and advocate promoting the use of advanced remote medical technologies.
Grant earned a B.A. in finance and investment banking from University of Wisconsin-Madison.
Alexis Gilroy advises health care and technology companies on health care and corporate matters with an emphasis on e-health topics (telemedicine, telehealth, and mobile health). She counsels and directs transactions involving venture capital, private equity, debt financing, joint ventures, mergers, acquisitions, management arrangements, physician engagement, hospital affiliation, and other general and complex contractual needs.
Alexis has broad experience with the practical and legal needs of health care companies, especially the unique legal issues faced by e-health companies. Prior to joining Jones Day, she managed more than 20 strategic M&A transactions for a publicly traded health care company that involved cyberknife, imaging centers, teleradiology companies, and radiation oncology centers. In addition, she advised on business strategy and implementation matters specific to e-health programs, business models, devices, and products; counseled on regulations regarding e-consults, reimbursements, online prescribing, patient consents, credentialing by proxy, corporate practice of medicine, physician supervision, reimbursement, anti-kickback, and licensure matters specific to e-health providers and businesses; developed and negotiated e-health specific customer, vendor, and affiliation contracts and documentation; structured research arrangements involving HIT (health information technology); and led strategy and communications with medical boards and other regulators and policy makers on e-health matters.
Alexis has spoken extensively on matters involving e-health, including testimony before legislative and regulatory bodies. She serves as chair of the Business & Finance Group of the American Telemedicine Association, was an appointee to the Maryland Governor's Telemedicine Taskforce, was a member of the Federation of State Medical Boards' workgroup on telehealth, and a past leader of the American Health Lawyer Association's E-Health and Telemedicine Affinity Group.
Saturday, April 22
9:00 AM – 12:00 PM
Senior Vice President and Managing Director
Tom Rodgers is the Senior Vice President and Managing Director leading McKesson Ventures. He spent more than a decade in health care venture capital, most recently leading strategic investing efforts for Cambia Health, and before that as a Partner with Advanced Technology Ventures.
Before his venture capital career, Rodgers had significant operating experience in the health care industry. He held various strategy and commercial roles at leading technology companies such as McKesson, Genentech, FitLinxx and The Wilkerson Group.
Rodgers holds an M.B.A. from the Wharton School and a B.A. from the University of Pennsylvania. He was an All-American rugby player and long ago the math team champion of New Hampshire. He requests that neither be held against him.
Ziegler Link-Age Longevity Fund, LP
John currently serves as the managing director of Link·age Ventures, Inc., and as chief investment officer of the Ziegler Link-age Longevity Fund. John is responsible for discovering and nurturing new investment opportunities. Regardless of whether it’s a start-up or an established company, or a product or service for the aging marketplace, John is interested in learning more. John brings a variety of experience to Link·age Ventures, which he joined in November 2011. With a background in both technology and banking, his areas of expertise include management consulting, strategic planning and business development.
Jeff is a partner at Providence Ventures, where he leads healthcare technology investments and manages fund operations. He is currently a board observer at Indemand Interpreting.
Prior to joining Providence, Jeff was an investment manager at Ascension Ventures in St. Louis, MO, where he also focused on the health care technology industry. During his tenure at Ascension Ventures, Jeff served as a director at Advanced Practice Strategies and a board observer at GetWellNetwork, CHF Solutions and OptiScan Biomedical Corporation.
Before Ascension Ventures, Jeff was a member of Ascension Health’s strategic development group, where he contributed to numerous system-level strategic initiatives and business development activities. Jeff has prior experience in software product management and business development for entrepreneurial health care technology companies WebMD, WellMed, and HealthLanguage (formerly, CyberPlus).
Jeff holds a master’s in business administration from the University of Chicago’s Booth School of Business, a master’s in science in medical informatics from the Oregon Health & Science University, and a bachelor’s of arts from the University of Chicago.
Chief Executive Officer
Echo Health Ventures
As CEO of Echo Health Ventures, Rob leads the company's efforts to identify, invest in and grow innovative companies that enable and deliver a transformed experience to health care consumers nationwide. As part of Echo's unique partnership with its parents, Rob works closely with the senior management teams and board of Cambia Health Solutions and Mosaic Health Solutions to support collaboration with Echo's portfolio companies, accelerate Cambia and Mosaic's strategies and more quickly bring health care innovation to national scale.
Rob has more than 20 years of experience in health care venture capital and business building. Before founding Echo, Rob served as the President of Cambia Health Solutions' diversified business unit (Direct Health Solutions). In this role, Rob oversaw Cambia's wholly-owned operating companies (including cost and quality transparency market leader HealthSparq; ancillary benefits provider LifeMap) as well as its venture and private equity investing activities. Rob joined Cambia in 2010 to launch and build the company's diversification and corporate venture investment efforts. Under Rob’s leadership, Cambia invested in nearly 20 companies.
In 2015, Rob cofounded the Cambia Grove - an innovation hub focused on catalyzing and supporting the Pacific Northwest’s emerging health care economic cluster. At the Cambia Grove, innovators and entrepreneurs work closely with regional stakeholders to find solutions to pressing health care challenges.
Before joining Cambia, Rob was the founding partner of Faultline Ventures, where he worked with numerous early stage companies and strategic investors. Previously, he was a Partner at Capitol Health Partners, a Washington, D.C., and New York City-based venture capital firm specializing in early-stage health services and health care information technology.
Active in industry and community organizations, Rob serves on the boards of several health care companies and is a founder and former director of the Nashville-based largest network of young health care executives, Leadership Health Care. Rob also serves on the board of directors at Life Science Washington (formerly Washington Biotechnology & Biomedical Association), the Oregon Museum of Science and Industry (OMSI), the Cambia Health Foundation and is a member of the Health Executives Network (HELN) and Fellow of the American Leadership Forum.
Rob is a graduate of Georgetown University with a degree in history and is a Chartered Financial Analyst, charter holder.